Stereotaxis, Inc. Form 8-K Summary
Business Context and Reporting Period
Stereotaxis, Inc. (STXS), a Delaware corporation, filed this Current Report on Form 8-K on July 17, 2025. The filing discloses the entry into a Material Definitive Agreement regarding a registered direct offering of common stock.
Key Financial Metrics and Transaction Details
The Company agreed to sell shares of Common Stock in a registered direct offering with the following terms:
- Total Offering Size: $12.5 million aggregate gross proceeds.
- Offering Price: $2.00 per share.
- Initial Closing (Expected July 18, 2025):
- Shares: 4,250,000 Initial Shares.
- Gross Proceeds: $8.5 million.
- Additional Closing (Expected November 25, 2025):
- Shares: 2,000,000 Additional Shares.
- Gross Proceeds: $4.0 million.
- Placement Agent Fees: 5.5% cash fee on the first $7.5 million of gross proceeds received at the Initial Closing. No fees apply to the remaining $1.0 million of the Initial Closing or the $4.0 million Additional Closing.
- Expense Reimbursement: Up to $100,000 for certain expenses and legal fees.
The filing does not provide current revenue, profit, cash flow, margin, or debt figures as this is a transactional filing rather than a periodic financial report.
Material Changes and Use of Proceeds
This filing represents a material change in the Company's capital structure through the issuance of new equity. The Company intends to use the net proceeds for:
- Working capital.
- Accelerating product commercialization.
- Research and development.
- Other general corporate purposes.
Guidance, Risks, and Forward-Looking Statements
The filing contains forward-looking statements regarding the anticipated use of proceeds and the timing of the Additional Closing. These statements are subject to risks and uncertainties, including the Company's ability to satisfy closing conditions and general market conditions. The Company explicitly states it does not undertake an obligation to update these statements except as required by law.
Key Facts for Investor Verification
- Verify the actual closing date and final share count for the Initial Closing on or after July 18, 2025.
- Confirm the identity of the Investors purchasing the Initial and Additional Shares.
- Review the full text of the Placement Agency Agreement (Exhibit 10.1) and Securities Purchase Agreement (Exhibit 10.2) for specific covenants and termination provisions.
- Monitor the Company's ability to meet the conditions precedent for the Additional Closing scheduled for November 25, 2025.
- Assess the dilution impact of the issuance of 6,250,000 total shares on existing shareholders.